v3.25.4
Stock-Based Compensation (Tables)
3 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense
Total stock-based compensation expense for the three months ended December 31, 2025 and 2024 and the respective income tax benefits recognized by the Company in the Condensed Consolidated Statements of Income are as follows:
 Three months ended December 31,
20252024
Cost of products sold$0.8 $0.6 
Selling and administrative expense5.0 7.4 
Research and development expense0.1 0.1 
Other operating (income) expense, net— 0.9 
Total Stock-Based Compensation Expense$5.9 $9.0 
Tax benefit associated with stock-based compensation costs recognized$0.8 $1.0 
The following table summarizes the Company's total stock-based compensation expense by classification of award for the three months ended December 31, 2025 and 2024:
Three months ended December 31,
20252024
Equity Awards$5.9 $8.9 
Liability Awards— 0.1 
Total$5.9 $9.0 
The following table summarizes the Company's total stock-based compensation expense by award type for the three months ended December 31, 2025 and 2024:
Three months ended December 31,
20252024
Time-Vested Restricted Stock Units (TVUs)
$5.0 $5.6 
Performance-Based Restricted Stock Units (PSUs)
0.6 2.9 
Stock Appreciation Rights (SARs)
0.3 0.5 
Total$5.9 $9.0 
Schedule of Time-Vested Restricted Stock Units Outstanding
A summary of TVUs outstanding as of December 31, 2025 and changes during the three months ended December 31, 2025 are as follows:
TVUs (in thousands)Weighted Average Grant Date Fair Value
Nonvested at October 12,055.4 $18.97 
Granted*1,817.4 12.57 
Distributed**(838.5)20.09 
Forfeited, canceled or expired(19.9)18.04 
Nonvested at December 313,014.4 $14.82 
Expected to vest at December 312,848.7 $14.83 
*Includes accumulated nonvested dividend equivalents
**The TVUs distributed include shares withheld for taxes that are not formally issued to the market.
Schedule of Performance Based Restricted Stock Units Outstanding
A summary of PSUs outstanding as of December 31, 2025 and changes during the three months ended December 31, 2025 are as follows:
Stock Units (in thousands)Weighted Average Grant Date Fair Value
Nonvested at October 1272.8 $22.63 
Granted*1,265.1 11.80 
Distributed
(279.0)18.96 
Nonvested at December 311,258.9 $11.82 
Expected to vest at December 311,189.6 $11.80 
*Includes accumulated nonvested dividend equivalents
Schedule of SAR's Outstanding and Changes
A summary of stock appreciation rights ("SARs") outstanding as of December 31, 2025 and changes during the three months ended December 31, 2025 are as follows:
SARs (in thousands)Weighted Average Exercise PriceWeighted Average Remaining Contractual Term (Years)Aggregate Intrinsic Value
Balance at October 11,443.3 $29.23 
Forfeited, canceled or expired(17.8)16.97 
Balance at December 311,425.5 $29.39 5.6$— 
Vested and expected to vest at December 311,423.7 29.39 5.6$— 
Exercisable at December 311,392.5 $29.34 5.6$— 
*The amounts exercised include shares withheld for taxes that are not formally issued to the market.